Mauro M Teixeira Selected Research

Sepsis (Septicemia)

1/2023	Plasmin and plasminogen prevent sepsis severity by reducing neutrophil extracellular traps and systemic inflammation.
1/2018	The Atypical Chemokine Receptor ACKR2 is Protective Against Sepsis.
3/2015	Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
9/2010	Phosphoinositide-3 kinase gamma activity contributes to sepsis and organ damage by altering neutrophil recruitment.
3/2009	Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis.
3/2007	Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide.
7/2006	Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis.
5/2002	Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro M Teixeira Research Topics

Disease

100	Inflammation (Inflammations) 06/2023 - 05/2002
72	Infections 01/2024 - 06/2002
22	Chagas Disease (American Trypanosomiasis) 10/2016 - 01/2002
20	Arthritis (Polyarthritis) 10/2023 - 06/2005
15	Reperfusion Injury 12/2007 - 05/2002
13	Gout 01/2022 - 02/2012
12	Pneumonia (Pneumonitis) 01/2022 - 02/2009
12	Ischemia 12/2007 - 04/2002
10	Wounds and Injuries (Trauma) 01/2019 - 01/2002
9	Pain (Aches) 06/2023 - 03/2010
9	Neoplasms (Cancer) 01/2022 - 01/2004
9	Edema (Dropsy) 01/2022 - 09/2004
9	Necrosis 10/2021 - 04/2002
9	Lung Injury 01/2020 - 03/2002
9	Asthma (Bronchial Asthma) 12/2018 - 10/2008
9	Fibrosis (Cirrhosis) 12/2018 - 04/2009
8	Dengue (Dengue Fever) 11/2023 - 12/2010
8	Sepsis (Septicemia) 01/2023 - 05/2002
8	Hemorrhage 08/2009 - 06/2003
7	Human Influenza (Influenza) 01/2024 - 11/2010
6	Virus Diseases (Viral Diseases) 01/2021 - 08/2014
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 03/2010
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018 - 04/2009
6	Hyperalgesia 08/2017 - 07/2014
6	Parasitemia 10/2016 - 06/2004
6	Cardiomyopathies (Cardiomyopathy) 11/2012 - 11/2002
5	COVID-19 04/2024 - 01/2022
5	Communicable Diseases (Infectious Diseases) 01/2024 - 01/2016
5	Pleurisy (Pleuritis) 01/2019 - 03/2002
4	Rheumatoid Arthritis 01/2022 - 09/2010
4	Zika Virus Infection 01/2021 - 01/2017
4	Thrombocytopenia (Thrombopenia) 05/2020 - 08/2009
4	Hypersensitivity (Allergy) 01/2018 - 11/2008
4	Colitis 03/2016 - 12/2009
4	Experimental Arthritis 01/2016 - 08/2010
4	Shock 01/2013 - 05/2002
4	Granuloma 04/2011 - 12/2002
4	Schistosomiasis mansoni 04/2011 - 12/2002
4	Heart Failure 08/2006 - 01/2004
3	Severe Dengue 11/2023 - 08/2009
3	Bone Resorption 07/2023 - 02/2015
3	Gouty Arthritis 06/2023 - 12/2020
3	Mucositis 01/2022 - 07/2014

Drug/Important Bio-Agent (IBA)

56	CytokinesIBA 11/2023 - 04/2004
43	ChemokinesIBA 10/2023 - 05/2002
31	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 04/2002
23	AntigensIBA 01/2021 - 11/2003
18	Interleukin-10 (Interleukin 10)IBA 01/2018 - 04/2002
13	Uric Acid (Urate)IBA 06/2023 - 06/2015
12	Chemokine ReceptorsIBA 01/2022 - 01/2004
11	Antiviral Agents (Antivirals)IBA 04/2024 - 08/2014
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
10	platelet activating factor receptorIBA 03/2014 - 03/2002
9	Peptides (Polypeptides)IBA 01/2022 - 11/2002
8	Annexin A1IBA 01/2022 - 08/2012
8	LigandsIBA 01/2019 - 12/2010
8	Platelet Activating FactorIBA 01/2012 - 03/2002
6	VaccinesIBA 10/2023 - 10/2006
6	GlucocorticoidsIBA 01/2022 - 08/2012
6	LipidsIBA 01/2021 - 07/2003
6	Interleukin-33IBA 12/2020 - 10/2008
6	Bleomycin (Blenoxane)FDA LinkGeneric 12/2018 - 04/2009
6	InflammasomesIBA 06/2018 - 02/2012
5	CaspasesIBA 07/2023 - 05/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2002
5	PlasminogenIBA 01/2023 - 10/2014
5	Acetates (Acetic Acid Esters)FDA Link 01/2020 - 04/2015
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 07/2006
5	Phosphotransferases (Kinase)IBA 01/2019 - 05/2005
5	InterferonsIBA 01/2018 - 04/2006
5	OvalbuminIBA 05/2011 - 05/2003
5	Endothelins (Endothelin)IBA 03/2010 - 01/2002
5	Interleukin-4 (Interleukin 4)IBA 01/2009 - 04/2006
5	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2006 - 07/2003
4	AntibodiesIBA 11/2023 - 05/2004
4	Fibrinolysin FDA Link 01/2023 - 10/2014
4	FibrinIBA 01/2023 - 01/2008
4	Interleukin-17 (Interleukin 17)IBA 01/2022 - 05/2011
4	CXC ChemokinesIBA 10/2021 - 09/2007
4	Messenger RNA (mRNA)IBA 01/2020 - 09/2013
4	Interleukin-8B ReceptorsIBA 12/2018 - 09/2004
4	CC ChemokinesIBA 01/2018 - 02/2009
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2007
4	RolipramIBA 01/2017 - 08/2009
4	LipopolysaccharidesIBA 01/2017 - 05/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 04/2006
4	Peroxidase (Myeloperoxidase)IBA 01/2016 - 01/2004
4	NitratesIBA 01/2012 - 04/2006
4	Interleukin-13IBA 05/2011 - 09/2006
4	CollagenIBA 04/2011 - 04/2005
4	EnzymesIBA 11/2010 - 05/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
3	Complement System Proteins (Complement)IBA 03/2022 - 08/2005
3	Protein Isoforms (Isoforms)IBA 01/2022 - 05/2005
3	Interleukin-22 (IL-22)IBA 01/2022 - 05/2011
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 07/2014
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021 - 11/2012

Therapy/Procedure

18	Therapeutics 09/2023 - 01/2004
6	Ligation 01/2023 - 05/2002
5	Punctures 01/2023 - 05/2002